The CROSSBRAIN consortium is highly interdisciplinary and deeply committed to excellence. It includes 9 partners from 5 European countries with a unique balance of world-class investigators and young researchers. CROSSBRAIN is committed to bringing innovation all the way from bench to bedside by taking on the challenge of designing radically new neuromodulation technologies based on novel physical principles.
This project has received funding from the European Union’s European Innovation Council, call HORIZON-EIC-2021-